Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 4

Исследование скелетной мускулатуры у пациентов с хронической обструктивной болезнью легких: обзор литературы
А.К. Сулейманова, И.А. Баранова

References
1. Feinstein AR. The pre-therapeutic classification of co-morbiditiy in chronic disease. Journal of Chronic Diseases 1970 Dec;23(7):455-68.
2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. The European Respiratory Journal 2009 May;33(5):1165-85.
3. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD; ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2014 May;189(9):e15-62.
4. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005 May;171(10):1116-24.
5. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, Wouters EF. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. The European Respiratory Journal 2010 Jul;36(1):81-8.
6. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI, Moxham J. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2003 Sep;168(5):562-7.
7. Polkey MI, Moxham J. Attacking the disease spiral in chronic obstructive pulmonary disease. Clinical Medicine (London, England) 2006 Mar-Apr;6(2):190-6.
8. Franssen FM, Sauerwein HP, Rutten EP, Wouters EF, Schols AM. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. The European Respiratory Journal 2008 Dec;32(6):1466-71.
9. González C, Servera E, Marín J. Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest 2008 Apr;133(4):941-7.
10. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. The European Respiratory Journal 2004 Jan;23(1):28-33.
11. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respiratory Research 2007 Mar;8:25.
12. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007 Feb;62(2):115-20.
13. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition 2000 Mar;71(3):733-8.
14. Debigaré R, Côte CH, Hould FS, LeBlanc P, Maltais F. In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. The European Respiratory Journal 2003 Feb;21(2):273-8.
15. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. American Journal of Respiratory and Critical Care Medicine 2006 Jan;173(1):79-83.
16. Maltais F. Body composition in COPD: looking beyond BMI. International Journal of Tuberculosis and Lung Disease 2014 Jan;18(1):3-4.
17. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition 2005;82(1):53-9.
18. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002 Sep;166(6):809-13.
19. Rosenberg IH. Sarcopenia: origins and clinical relevance. The Journal of Nutrition 1997 May;127(5 Suppl):990S-1S.
20. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age & Ageing 2010;39:412-23.
21. International Classification of Diseases 10th Revision. Available from: https://icdlist.com/icd-10/M62.84 Accessed 2019 May 28.
22. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2); the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age & Ageing 2019 Jan;48(1):16-31.
23. Mijnarends DM, Luiking YC, Halfens RJG, Evers SMAA, Lenaerts ELA, Verlaan S, Wallace M, Schols JMGA, Meijers JMM. Muscle, health and costs: a glance at their relationship. The Journal of Nutrition, Health and Aging 2018;22(7):766-73.
24. Schaap LA, van Schoor NM, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences 2018 Aug;73(9):1199-204.
25. Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. Journal of Cachexia, Sarcopenia and Muscle 2016 Mar;7(1):28-36.
26. Bahat G, Ilhan B. Sarcopenia and the cardiometabolic syndrome: a narrative review. European Geriatric Medicine 2016 Jun;7(3):220-3.
27. Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chronic Respiratory Disease 2017 Feb;14(1):85-99.
28. Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. Journal of the American Medical Directors Association 2016 Dec;17(12):1164.e7-e15.
29. Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, Petermans J, Gillain S, Buckinx F, Van Beveren J, Jacquemain M, Italiano P, Dardenne N, Bruyere O. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age & Ageing 2015 Nov;44(6):960-6.
30. Steffl M, Bohannon RW, Sontakova L, Tufano JJ, Shiells K, Holmerova I. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clinical Interventions in Aging 2017 May;12:835-45.
31. De Buyser SL, Petrovic M, Taes YE, Toye KR, Kaufman JM, Lapauw B, Goemaere S. Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age & Ageing 2016 Sep;45(5):602-8.
32. Cawthon PM, Lui LY, Taylor BC, McCulloch C, Cauley JA, Lapidus J, Orwoll E, Ensrud KE. Clinical definitions of sarcopenia and risk of hospitalization in community-dwelling older men: the osteoporotic fractures in men study. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences 2017 Oct;72(10):1383-9.
33. Sousa AS, Guerra RS, Fonseca I, Pichel F, Ferreira S, Amaral TF. Financial impact of sarcopenia on hospitalization costs. European Journal of Clinical Nutrition 2016 Sep;70(9):1046-51.
34. Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, Polkey MI, Man WD. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 2015 Mar;70(3):213-8.
35. Costa TM, Costa FM, Moreira CA, Rabelo LM, Boguszewski CL, Borba VZ. Sarcopenia in COPD: relationship with COPD severity and prognosis. Jornal Brasileiro de Pneumologia 2015 Sep-Oct;41(5):415-21.
36. Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. International Journal of Chronic Obstructive Pulmonary Disease 2017 Feb;12:669-75.
37. Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age & Ageing 2013 Mar;42(2):203-9.
38. Ibrahim K, May C, Patel HP, Baxter M, Sayer AA, Roberts H. A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol. Pilot and Feasibility Studies 2016 Jun;2:27.
39. Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Bertière MC, Brandi ML, Al-Daghri NM, Burlet N, Cavalier E, Cerreta F, Cherubini A, Fielding R, Gielen E, Landi F, Petermans J, Reginster JY, Visser M, Kanis J, Cooper C. Sarcopenia in daily practice: assessment and management. BMC Geriatrics 2016 Oct;16(1):170.
40. Syddall HE, Martin HJ, Harwood RH, Cooper C, Aihie Sayer A. The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. Journal of Nutrition, Health and Aging 2009 Jan;13(1):57-62.
41. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine 2001 Jul;33(5):337-43.
42. Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V. Muscle and bone, two interconnected tissues. Ageing Research Reviews 2015 May;21:55-70.
43. Choi KM. Sarcopenia and sarcopenic obesity. The Korean Journal of Internal Medicine 2016 Nov;31(6):1054-60.
44. Ilich JZ, Kelly OJ, Inglis JE. Osteosarcopenic obesity syndrome: what is it and how can it be identified and diagnosed? Current Gerontology and Geriatrics Research 2016;2016:7325973.
45. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Research Reviews 2017 May;5:200-21.
46. Tian S, Xu Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatrics & Gerontology International 2016 Feb;16(2):155-66.
47. Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PloS One 2014 Oct;9(10):e110448.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]